Wenqian Dong

2.4k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Wenqian Dong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wenqian Dong has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Wenqian Dong's work include RNA Interference and Gene Delivery (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Wenqian Dong is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Wenqian Dong collaborates with scholars based in China, Canada and United States. Wenqian Dong's co-authors include Jingwei Ma, Degao Chen, Xiaoyu Liang, Ke Tang, Yi Zhang, Yuying Liu, Bo Huang, Jiadi Lv, Jing Xie and Xun Jin and has published in prestigious journals such as Nature Communications, ACS Nano and Nature Cell Biology.

In The Last Decade

Wenqian Dong

17 papers receiving 1.2k citations

Hit Papers

Chloroquine modulates antitumor immune response by resett... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenqian Dong China 16 578 470 266 235 200 17 1.2k
Sharareh Gholamin United States 16 521 0.9× 619 1.3× 462 1.7× 312 1.3× 129 0.6× 36 1.5k
Direna Alonso‐Curbelo United States 14 947 1.6× 595 1.3× 540 2.0× 260 1.1× 97 0.5× 20 1.9k
Davide Brusa Italy 23 517 0.9× 717 1.5× 673 2.5× 223 0.9× 107 0.5× 58 1.7k
Suprit Gupta United States 9 525 0.9× 402 0.9× 462 1.7× 222 0.9× 85 0.4× 13 1.2k
Huafeng Zhang China 17 609 1.1× 259 0.6× 319 1.2× 335 1.4× 288 1.4× 30 1.3k
Xianda Zhao United States 20 631 1.1× 306 0.7× 545 2.0× 363 1.5× 118 0.6× 41 1.3k
Yuli Wang China 22 1.0k 1.8× 242 0.5× 358 1.3× 277 1.2× 160 0.8× 51 1.4k
Huiyin Lan China 11 931 1.6× 608 1.3× 508 1.9× 529 2.3× 145 0.7× 18 1.7k
Wenlin Du Japan 19 554 1.0× 258 0.5× 320 1.2× 195 0.8× 54 0.3× 36 1.1k

Countries citing papers authored by Wenqian Dong

Since Specialization
Citations

This map shows the geographic impact of Wenqian Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqian Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqian Dong more than expected).

Fields of papers citing papers by Wenqian Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqian Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqian Dong. The network helps show where Wenqian Dong may publish in the future.

Co-authorship network of co-authors of Wenqian Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqian Dong. A scholar is included among the top collaborators of Wenqian Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqian Dong. Wenqian Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dong, Wenqian, Shuang Zhang, Yujie Kong, et al.. (2024). Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer. Cellular Oncology. 48(1). 249–264. 4 indexed citations
2.
Wang, Liren, Zhiqi Lin, Yuhao Kang, et al.. (2022). Regulating Macrophages through Immunomodulatory Biomaterials Is a Promising Strategy for Promoting Tendon-Bone Healing. Journal of Functional Biomaterials. 13(4). 243–243. 31 indexed citations
3.
Zhang, Shuang, Xiaolei Zhang, Pingping Wei, et al.. (2020). LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer. Life Sciences. 267. 118933–118933. 16 indexed citations
4.
Wang, Yi, Yao‐Xin Lin, Jie Wang, et al.. (2019). In Situ Manipulation of Dendritic Cells by an Autophagy-Regulative Nanoactivator Enables Effective Cancer Immunotherapy. ACS Nano. 13(7). 7568–7577. 71 indexed citations
5.
Zhang, Huafeng, Yuandong Yu, Li Zhou, et al.. (2018). Circulating Tumor Microparticles Promote Lung Metastasis by Reprogramming Inflammatory and Mechanical Niches via a Macrophage-Dependent Pathway. Cancer Immunology Research. 6(9). 1046–1056. 48 indexed citations
6.
Liu, Yuying, Jiadi Lv, Xiaoyu Liang, et al.. (2018). Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program. Cancer Research. 78(14). 3926–3937. 88 indexed citations
7.
Chen, Degao, Jing Xie, Roland Fiskesund, et al.. (2018). Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nature Communications. 9(1). 873–873. 389 indexed citations breakdown →
8.
Ma, Ruihua, Tiantian Ji, Yi Zhang, et al.. (2017). A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells. Nature Cell Biology. 20(1). 21–27. 151 indexed citations
9.
Dong, Wenqian, Huafeng Zhang, Xiaonan Yin, et al.. (2017). Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity. OncoImmunology. 6(3). e1282589–e1282589. 31 indexed citations
10.
Li, Ran, Yanchun Li, Huafeng Zhang, et al.. (2016). Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials. 89. 56–66. 85 indexed citations
11.
Ma, Ruihua, Tiantian Ji, Degao Chen, et al.. (2016). Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression. OncoImmunology. 5(4). e1118599–e1118599. 100 indexed citations
12.
Chen, Xueying, Wei Zhang, Peng Li, et al.. (2016). Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition. Oncotarget. 7(21). 31053–31066. 27 indexed citations
13.
Dong, Wenqian, Qinghua Lu, Wei Zhang, et al.. (2015). Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy. Oncotarget. 7(1). 66–80. 30 indexed citations
14.
Chen, Xueying, Guoliang Liu, Wei Zhang, et al.. (2015). Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-β1/Smad activation in cardiac fibroblasts. The International Journal of Biochemistry & Cell Biology. 69. 52–61. 29 indexed citations
16.
Wang, Lingbo, Weili Cai, Wei Zhang, et al.. (2015). Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene. Oncotarget. 6(29). 27490–27504. 24 indexed citations
17.
Wang, Xuping, Wei Zhang, Xiaoqian Liu, et al.. (2013). Arginase I enhances atherosclerotic plaque stabilization by inhibiting inflammation and promoting smooth muscle cell proliferation. European Heart Journal. 35(14). 911–919. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026